octylonium has been researched along with Colitis, Mucous in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Helal, ME; Rashid, A; Zaki, SA | 1 |
| Cox, JF | 1 |
| Baccari, MC; Biagioni, C; Idrizaj, E; Traini, C; Vannucchi, MG | 1 |
| Mittal, A; Shrivastava, A | 1 |
| Baccari, MC; Faussone-Pellegrini, MS; Garella, R; Idrizaj, E; Traini, C; Vannucchi, MG | 1 |
| Baeg, MK; Choi, JS; Ha, H; Kim, HJ; Kim, J; Kim, JI; Kim, P; Kim, YJ; Lee, JH; Park, TY; Sunwoo, YY; Yang, NR | 1 |
| Evangelista, S; Traini, C; Vannucchi, MG | 1 |
| Boeckxstaens, G; Clavé, P; Corazziari, ES; Tack, J | 1 |
| Annaházi, A; Róka, R; Rosztóczy, A; Wittmann, T | 1 |
| Chmielewska-Wilkoń, D; Egan, CG; Reggiardo, G | 1 |
| Boeckxstaens, G; Camilleri, M | 1 |
| Acalovschi, M; Clavé, P; Kalayci, C; Shee, V; Tack, J; Triantafillidis, JK; Uspensky, YP | 1 |
| Forte, E; Lopetuso, L; Pizzoferrato, M; Scaldaferri, F | 1 |
| Boeckxstaens, G; Corazziari, ES; Mearin, F; Tack, J | 1 |
| Evangelista, S; Farrugia, G; Lyford, GL; Sarr, MG; Strege, PR | 1 |
| Evangelista, S | 1 |
| Spinelli, A | 1 |
9 review(s) available for octylonium and Colitis, Mucous
| Article | Year |
|---|---|
A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide.
Topics: Abdominal Pain; Acetonitriles; Antidiarrheals; Chloroform; Cholinergic Antagonists; Humans; Irritable Bowel Syndrome; Methanol; Parasympatholytics; Quality of Life; Quaternary Ammonium Compounds; Solvents | 2022 |
Otilonium Bromide: A Drug with a Complex Mechanism of Action.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Humans; Irritable Bowel Syndrome; Quaternary Ammonium Compounds | 2018 |
Irritable bowel syndrome: focus on otilonium bromide.
Topics: Abdominal Pain; Calcium; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Quaternary Ammonium Compounds; Treatment Outcome | 2014 |
Role of antispasmodics in the treatment of irritable bowel syndrome.
Topics: Abdominal Pain; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Phenethylamines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Dietary and pharmacological treatment of abdominal pain in IBS.
Topics: Abdominal Pain; Anti-Infective Agents; Antidepressive Agents; Butyrophenones; Dipeptides; GABA Agents; Gastrointestinal Agents; Histamine H1 Antagonists; Humans; Imidazoles; Irritable Bowel Syndrome; Mentha piperita; Parasympatholytics; Phenylalanine; Piperidines; Plant Oils; Probiotics; Quaternary Ammonium Compounds; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists; Thiophenes; Visceral Pain | 2017 |
The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
Topics: Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Parasympatholytics; Quaternary Ammonium Compounds; Survival Analysis | 2012 |
IBS and the role of otilonium bromide.
Topics: Clinical Trials as Topic; Cost of Illness; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Parasympatholytics; Quaternary Ammonium Compounds | 2013 |
Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
Topics: Butylscopolammonium Bromide; Clinical Trials as Topic; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Quaternary Ammonium Compounds; Scopolamine Derivatives; Structure-Activity Relationship | 2004 |
Irritable bowel syndrome.
Topics: Clinical Trials as Topic; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Models, Biological; Parasympatholytics; Quaternary Ammonium Compounds; Treatment Outcome | 2007 |
3 trial(s) available for octylonium and Colitis, Mucous
| Article | Year |
|---|---|
Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial.
Topics: Abdominal Pain; Clinical Protocols; Defecation; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Irritable Bowel Syndrome; Male; Muscarinic Antagonists; Plant Extracts; Quaternary Ammonium Compounds; Republic of Korea | 2017 |
Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
Topics: Abdominal Pain; Adult; Defecation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Pain Measurement; Poland; Quaternary Ammonium Compounds; Time Factors; Treatment Outcome | 2014 |
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
Topics: Abdominal Pain; Adult; Aged; Calcium Channels, L-Type; Dilatation, Pathologic; Double-Blind Method; Female; Follow-Up Studies; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Muscle, Smooth; Quaternary Ammonium Compounds; Severity of Illness Index; Statistics as Topic; Surveys and Questionnaires; Time Factors | 2011 |
5 other study(ies) available for octylonium and Colitis, Mucous
| Article | Year |
|---|---|
Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report.
Topics: Animals; Drug Overdose; Female; Humans; Irritable Bowel Syndrome; Quaternary Ammonium Compounds | 2022 |
In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk.
Topics: Diet; Diet, Carbohydrate-Restricted; Humans; Irritable Bowel Syndrome; Quaternary Ammonium Compounds; Self-Management; Smartphone | 2022 |
Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome.
Topics: Animals; Colon; Humans; Irritable Bowel Syndrome; Muscarinic Antagonists; Rats; Receptors, Corticotropin-Releasing Hormone; Water | 2023 |
Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model.
Topics: Animals; Colon; Corticotropin-Releasing Hormone; Gastrointestinal Agents; Irritable Bowel Syndrome; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological | 2021 |
Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle.
Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Humans; Intestinal Mucosa; Intestines; Irritable Bowel Syndrome; Membrane Potentials; Muscle, Smooth; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channels; Quaternary Ammonium Compounds; Sodium Channels | 2004 |